Obesity Clinical Trial
— ACTION-IOOfficial title:
Awareness, Care & Treatment In Obesity Management - An International Observation (ACTION-IO)
Verified date | May 2019 |
Source | Novo Nordisk A/S |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The purpose of this survey is to collect the data on perceptions, behaviours and awareness related to obesity and obesity management for People with Obesity (PwO) and Health Care Professionals (HCP) treating obesity. Data will be collected via online surveys among each of the respondent groups. The surveys are expected to take approximately 25 minutes to complete and will be unique for PwO and HCP. As a cross-sectional study, there will be no treatment of patients.
Status | Completed |
Enrollment | 17287 |
Est. completion date | October 10, 2018 |
Est. primary completion date | October 10, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A and older |
Eligibility | Inclusion Criteria: - PEOPLE WITH OBESITY - Age at least 18 years, both males and females - On-line consent to participate in study - Lives in one of the participating countries: Italy, Spain, United Kingdom (UK), Brazil, Chile, Mexico, Australia, Israel, Saudi Arabia, United Arab Emirates (UAE), Japan, South Korea - Current Body Mass Index (BMI) (based on self-reported height and weight) greater than or equal to 30 kg/sqm in Italy, Spain, UK, Brazil, Chile, Mexico, Australia, Israel, Saudi Arabia, UAE; current BMI greater than or equal to 25 kg/sqm in Japan and South Korea - HEALTH CARE PROFESSIONALS - Physician - Specialty is NOT plastic surgeon, general surgeon, or bariatric surgeon - Practices in one of the participating countries: Italy, Spain, UK, Brazil, Chile, Mexico, Australia, Israel, Saudi Arabia, UAE, Japan, South Korea - In practice at least 2 years - Spends at least 70 percent of time in direct patient care - Has seen at least 100 patients in past month - Has seen at least 10 patients in past month needing weight management defined as: a patient with a BMI greater than or equal to 30 kg/sqm with or without comorbidities. (BMI greater than or equal to 25 kg/sqm in Japan and South Korea) Exclusion Criteria: - PEOPLE WITH OBESITY - Declines to provide income - Previous participation in this study. Participation is defined as having given online consent in this study - Declines to provide race / ethnicity (in applicable countries) - Currently pregnant - Participates in intense fitness or body building programs - Has had significant, unintentional weight loss (due to major injury, illness, etc.) in the past 6 months |
Country | Name | City | State |
---|---|---|---|
Australia | Novo Nordisk Investigational Site | Baulkham Hills | New South Wales |
Israel | Novo Nordisk Investigational Site | Kfar Saba | |
Korea, Republic of | Novo Nordisk Investigational Site | Seoul | |
Mexico | Novo Nordisk Investigational Site | Polanco | |
Saudi Arabia | Novo Nordisk Investigational Site | Riyadh | |
Spain | Novo Nordisk Investigational Site | Madrid | |
Switzerland | Novo Nordisk Investigational Site | Zürich | |
United Arab Emirates | Novo Nordisk Investigational Site | Dubai | |
United Kingdom | Novo Nordisk Investigational Site | Gatwick |
Lead Sponsor | Collaborator |
---|---|
Novo Nordisk A/S |
Australia, Israel, Korea, Republic of, Mexico, Saudi Arabia, Spain, Switzerland, United Arab Emirates, United Kingdom,
Caterson ID, Alfadda AA, Auerbach P, Coutinho W, Cuevas A, Dicker D, Hughes C, Iwabu M, Kang JH, Nawar R, Reynoso R, Rhee N, Rigas G, Salvador J, Sbraccia P, Vázquez-Velázquez V, Halford JCG. Gaps to bridge: Misalignment between perception, reality and ac — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Weight loss motivators | Online questionnaire - Multiple Item Selection | Start of interviews day 1 until end of data collection day 90 | |
Primary | Proportion of PwO / patients who made serious weight loss effort | Online questionnaire - Numeric Response | Start of interviews day 1 until end of data collection day 90 | |
Primary | Response to weight loss discussions | Online questionnaire - Single Item Selection | Start of interviews day 1 until end of data collection day 90 | |
Primary | Effective weight loss methods | Online questionnaire - Multiple Item Selection | Start of interviews day 1 until end of data collection day 90 | |
Primary | Obesity attitudes | Online questionnaire - End-anchored 5-point Likert agreement scale (from "1", do not agree at all, to "5" completely agree) | Start of interviews day 1 until end of data collection day 90 | |
Primary | Attitudes toward prescription weight loss medication and surgery | Online questionnaire - End-anchored 5-point Likert agreement scale (from "1", do not agree at all, to "5" completely agree) | Start of interviews day 1 until end of data collection day 90 | |
Primary | Weight loss barriers | Online questionnaire - End-anchored 5-point Likert agreement scale(from "1", do not agree at all, to "5" completely agree) | Start of interviews day 1 until end of data collection day 90 | |
Primary | Obesity and weight management | Online questionnaire - End-anchored 5-point Likert agreement scale(from "1", do not agree at all, to "5" completely agree) | Start of interviews day 1 until end of data collection day 90 | |
Primary | Degree to which healthcare and society is meeting needs of people with obesity | Online questionnaire - End-anchored 5-point Likert needs scale(from "1", do not agree at all, to "5" completely agree) | Start of interviews day 1 until end of data collection day 90 | |
Secondary | Top factors for improving weight loss outcomes | Online questionnaire - Ranking Exercise | Start of interviews day 1 until end of data collection day 90 | |
Secondary | Types of weight management goals | Online questionnaire - Multiple Item Selection | Start of interviews day 1 until end of data collection day 90 | |
Secondary | Most helpful information for patients for weight loss | Online questionnaire - Multiple Item Selection | Start of interviews day 1 until end of data collection day 90 | |
Secondary | Responsibility for improving health of people with obesity | Online questionnaire - Multiple Item Selection | Start of interviews day 1 until end of data collection day 90 | |
Secondary | Most helpful support for weight loss | Online questionnaire - Multiple Item Selection | Start of interviews day 1 until end of data collection day 90 | |
Secondary | Effectiveness of guidelines for treating obesity | Online questionnaire - Fully-anchored 5-point Likert scale (from "1", do not agree at all, to "5" completely agree) | Start of interviews day 1 until end of data collection day 90 | |
Secondary | Ways you receive information on weight loss management | Online questionnaire - Multiple Item Selection | Start of interviews day 1 until end of data collection day 90 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04243317 -
Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults
|
N/A | |
Recruiting |
NCT04101669 -
EndoBarrier System Pivotal Trial(Rev E v2)
|
N/A | |
Terminated |
NCT03772886 -
Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball
|
N/A | |
Completed |
NCT03640442 -
Modified Ramped Position for Intubation of Obese Females.
|
N/A | |
Completed |
NCT04506996 -
Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2
|
N/A | |
Recruiting |
NCT06019832 -
Analysis of Stem and Non-Stem Tibial Component
|
N/A | |
Active, not recruiting |
NCT05891834 -
Study of INV-202 in Patients With Obesity and Metabolic Syndrome
|
Phase 2 | |
Active, not recruiting |
NCT05275959 -
Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI)
|
N/A | |
Recruiting |
NCT04575194 -
Study of the Cardiometabolic Effects of Obesity Pharmacotherapy
|
Phase 4 | |
Completed |
NCT04513769 -
Nutritious Eating With Soul at Rare Variety Cafe
|
N/A | |
Withdrawn |
NCT03042897 -
Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer
|
N/A | |
Completed |
NCT03644524 -
Heat Therapy and Cardiometabolic Health in Obese Women
|
N/A | |
Recruiting |
NCT05917873 -
Metabolic Effects of Four-week Lactate-ketone Ester Supplementation
|
N/A | |
Active, not recruiting |
NCT04353258 -
Research Intervention to Support Healthy Eating and Exercise
|
N/A | |
Completed |
NCT04507867 -
Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III
|
N/A | |
Recruiting |
NCT03227575 -
Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control
|
N/A | |
Completed |
NCT01870947 -
Assisted Exercise in Obese Endometrial Cancer Patients
|
N/A | |
Recruiting |
NCT06007404 -
Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
|
||
Recruiting |
NCT05972564 -
The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function
|
Phase 1/Phase 2 | |
Recruiting |
NCT05371496 -
Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction
|
Phase 2 |